Modus Therapeutics reveals latest sevuparin data
New top line data has emerged from the company’s phase 1b study evaluating potential for treating sepsis
Read More
Tag: Modus
Modus completes recruitment for sevuparin study
Phase 1b study evaluates effects of sevuparin on the symptoms of volunteer participants
Read More
First patient enrolled in Modus’ sevuparin trial
Research is evaluating the therapy among paediatric patients with severe malaria
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
